Riskpilot← Back to searchSign inGet full accessImmuvance AB
ABActiveOrg 5593778508Donnerstigen 6Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20220 employees
Revenue 2024
SEK 0
EBITDA margin
—
Equity ratio
52.0%
Financial strength
Net profit 2024
SEK 0
+100% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | — | — |
| Net profit | SEK 0 | +100% |
| Total assets | SEK 25K | +0% |
| Equity | SEK 13K | +0% |
| Employees | 0 | — |
Legal name
Immuvance AB
Org number
5593778508
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
27 april 2022
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska, direkt eller indirekt genom dotterbolag, bedriva forskning och utveckling inom det medicinska området, inneha och förvalta immateriella rättigheter samt bedriva därmed förenlig verksamhet. Bolaget ska verka för att utveckla immunologiska terapier för behandling av infektioner, cancer och förebygga sjukdom genom att utveckla vacciner. Bolaget får även äga och förvalta aktier i andra bolag samt genomföra emissioner, fusioner och kapitalanskaffningar i syfte att främja bolagets utveckling.
Address
Donnerstigen 6
Email
winqvist.jonas@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Staff expenses | — | — | — |
| EBITDA | — | — | — |
| Depreciation & amort. | −0 | −0 | −0 |
| EBIT | 0 | 0 | 0 |
| Net financials | — | −26 | — |
| Profit before tax | 0 | −13 | 0 |
| Tax | −0 | −0 | −0 |
| Net profit | 0 | −13 | 0 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 25 | 25 | 25 |
| Equity | 25 | 13 | 13 |
| Long-term debt | 0 | 0 | 0 |
| Short-term debt | 0 | 13 | 13 |
| Total debt | — | 13 | 13 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20222024
Equity ratio
52.0%
This company
38.2%
Market median
+36% vs market
20222024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20222024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20222024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20222024
Debt / equity
0.92×
This company
0.62×
Market median
+48% vs market
20222024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-04-01 – 2022-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SJ Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2023 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2023 | — | — | |
| Deputy Board Member | 2025 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2023 | — | — | |
| Deputy Board Member | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Immuvance AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stig Jonas Winqvist | Chief Executive Officer | 0 companies |
| Hesham Ali Abdel Shakour | Board of Directors | 0 companies |
| Lars Hugo Viking Rillner | Deputy Board Member | 0 companies |
| Stina Maria Selldén | Deputy Board Member | 0 companies |
| Aleksandar Gocic | Board of Directors | 0 companies |
| Mamdouh Abdou El Imam | Chairman | 0 companies |
| Ingemar Carl Joakim Ewetz | Board of Directors | 0 companies |
| Eva Charlotta Ewetz | Deputy Board Member | 0 companies |
| Johan Peter Nylund | Chairman | 0 companies |
| Therese Lilly Felicia Wickström | Board of Directors | 0 companies |
| Carl-Henrik Mathias Lunneryd | Board of Directors | 0 companies |
| Lars Göran Ode | Board of Directors | 0 companies |
| Vito Ingrosso | Board of Directors | 0 companies |
| Viola Susann Winqvist | Deputy Board Member | 0 companies |
| Mikaela Jenni Berglund | Board of Directors | 0 companies |
| Stig Ola Winqvist | Board of Directors | 0 companies |
| Ros-Mari Wickström | Deputy Board Member | 0 companies |